Clinical
Health
I/O
Cybernetic
Social
More
- Opinion
- My Bookmarks

Clinical
Health
I/O
Cybernetic
Social
Opinion

Search

Clinical
Health
I/O
Cybernetic
Social
More
- Opinion
- My Bookmarks

Follow US

Twitter
Facebook
Instagram
Inc. Profile
Google Play Store

© 2022 - Mental Daily. All Rights Reserved.

Tag: GSK3-beta

Study shows how inhibiting norepinephrine signaling may improve cognitive deficits in Alzheimer’s disease

The findings appeared in Science Translational Medicine.

Staff Writer 2 Min Read

//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

Clinical
Health
Social
I/O
Opinion

Social

Twitter
Facebook
Instagram
Inc. Profile
Google Play Store

Links

About
Contact
The Editor
Terms & Conditions
Privacy Policy

Follow US

© 2022 Mental Daily. All Rights Reserved.

Twitter
Facebook
Instagram
Inc. Profile
Google Play Store

Removed from reading list

Undo

Welcome Back!

Sign in to your account

Username or Email Address

Password

Remember Me

Lost your password?